This article was originally published in The Tan Sheet
Executive SummarySabinsa Corp. announces April 14 it has secured a U.S. patent for its branded ingredient Cococin, a freeze-dried powder form of green coconut water. The patent also secures exclusive rights to "the resulting vitamin-rich composition and its intended uses in cosmetics, supplements and foods and beverages to support healthy cell growth and improve overall dermal health, among others," Sabinsa says. Cococin also received a European patent for process, composition and use in the European Market, the Piscataway, N.J.-based firm says...
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.